Application of a High-Content Multiparameter Cytotoxicity Assay to Prioritize Compounds Based on Toxicity Potential in Humans

Lasser, 2002, Timing of new black box warnings and withdrawals for prescription medications., JAMA, 287, 2215, 10.1001/jama.287.17.2215 Fung, 2001, Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets: 1960 to 1999., Drug Inf J, 35, 293, 10.1177/009286150103500134 Olson, 2000, Concordance of the toxicity of pharmaceuticals in humans and in animals., Regul Toxicol Pharmacol, 32, 56, 10.1006/rtph.2000.1399 Haskins, 2001, Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes., Arch Toxicol, 75, 425, 10.1007/s002040100251 Abraham, 2004, High content screening applied to large-scale cell biology., Trends Biotechnol, 22, 15, 10.1016/j.tibtech.2003.10.012 Abraham, 2004, Automated classification of individual cellular responses across multiple targets., Preclinica, 2, 349 Vogt, 2004, A scalable high-content cytotoxicity assay insensitive to changes in mitochondrial metabolic activity., Oncol Res, 14, 305, 10.3727/096504003773994842 O’Brien, 2006, High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening., Arch Toxicol, 80, 580, 10.1007/s00204-006-0091-3 Diaz, 2007, Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells., Mutat Res, 630, 1, 10.1016/j.mrgentox.2007.02.006 Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays., J Biomol Screen, 4, 67, 10.1177/108705719900400206 Balijepalli, 1999, Inhibition of mitochondrial complex I by haloperidol: the role of thiol oxidation., Neuropharmacology, 38, 567, 10.1016/S0028-3908(98)00215-9 Saravolatz, 2001, Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae., J Antimicrob Chemother, 47, 875, 10.1093/jac/47.6.875 Cohen, 1998, Effect of synthetic HMG-CoA reductase inhibitors on cholesterol synthesis in various human cell types and on progesterone secretion from human granulosa cells in culture., Artherosclerosis, 136, S56, 10.1016/S0021-9150(97)84614-X Willson, 2000, The PPARs: from orphan receptors to drug discovery., J Med Chem, 43, 527, 10.1021/jm990554g Liguori, 2005, Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin., Hepatology, 41, 177, 10.1002/hep.20514 Axel, 2000, Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures., J Cardiovasc Pharmacol, 35, 619, 10.1097/00005344-200004000-00016 Williams, 2006, Toxicophores: investigations in drug safety., Toxicology, 226, 1, 10.1016/j.tox.2006.05.101 Kalgutkar, 2005, A comprehensive listing of bioactivation pathways of organic functional groups., Curr Drug Metab, 63, 161, 10.2174/1389200054021799 Mills, 2004, Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line., J Pharmacol Exp Ther, 309, 303, 10.1124/jpet.103.061713 Suter, 2004, Toxicogenomics in predictive toxicology in drug development., Chem Biol, 11, 161, 10.1016/j.chembiol.2004.02.003